Thirty-Day and One-Year Outcomes of the Navitor TAVR System in Patients with Low or Intermediate Risk

<p>Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: </p><ul><li>Consultant Fee/Honoraria/Speaker's Bureau - Abbott; Edwards Lifesciences; Highlife Medical</li><li>Equity/Stock(s)/Options - Three Peaks Medical</li><li> - Three Peaks Medical</li></ul>